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Zusammenfassung
!
Ziel: Hauptziel: Die Bestimmung der Effektivität
der kontrastverstärkten Sonografie (CEUS) im
Vergleich mit der Multi-Detektor-Computer-
tomografie-Urografie (MDCTU) und der Magnet-
resonanz-Urografie (MRU) bei der Diagnose von
Malignomen des oberen Harntraktes. Sekundäre
Ziele: Vergleich der durch CEUS, MDCTU und
MRU gemessenen Tumorgröße und die Bewer-
tung des Nutzens von CEUS bei der Unterschei-
dung von hoch- und niedriggradigen Tumoren.
Material und Methoden: In Zusammenhang mit
dieser retrospektiven Studie, die von Januar 2009
bis September 2011 durchgeführt wurde, wurde
bei 18 Patienten MDCTU oder MRU, Graustufen-
Ultraschall (US), Farbdoppler-Sonografie und
CEUS nach der Operation und eine histologischen
Untersuchung der Präparats durchgeführt. Die
quantitative Analyse wurde unter Verwendung
einer Perfusionssoftware durchgeführt; Zeit-In-
tensitätskurven wurden extrahiert und folgende
Parameter wurden berücksichtigt: Wash-in-Zeit,
Zeit zur Spitze, maximale Signalintensität und
Wash-out-Zeit.
Ergebnisse: Der Graustufenultraschall entdeckte
15/18 Läsionen, der Farbdoppler zeigte in 8 Lä-
sionen kein Flusssignal, in 9 Läsionen niedrige
Farbsignale und in einem Herd ein deutliches
Farbsignal; CEUS erkannte 17/18 Herdbefunde,
die nicht nachgewiesene Läsion war die Kleinste
(1,2 cm) und befand sich im Nierenbeckenkelch-
system. Die semiquantitative Analyse führte zu
unterschiedlichen Ergebnissen für hoch- und
niedriggradige urotheliale Zellkarzinome (UCC).
Alle nachgewiesenen Raumforderungen des obe-
ren Harntraktes waren UCCs. MRU, MDCTU und
der Graustufenultraschall überschätzten die
Tumorgröße, während CEUS am genauesten war.
Schlussfolgerung: CEUS ist für die Bewertung
von Raumforderungen des oberen Harntraktes
geeignet, da diese Methode eine Differenzierung
Abstract
!
Purpose: The main objective was to assess the ef-
fectiveness of contrast-enhanced ultrasonogra-
phy (CEUS) in the diagnosis of upper urinary tract
malignancies by comparing with multidetector
computed tomographic urography (MDCTU) and
magnetic resonance urography (MRU). Secondary
objectives were to compare the tumor size meas-
ured with CEUS, MDCTU and MRU and to assess
the usefulness of CEUS in distinguishing high-
grade tumors from low-grade ones.
Materials and Methods: In connection with this
prospective study carried out from January
2009 to September 2011, 18 patients underwent
MDCTU or MRU, grayscale ultrasonography (US),
color Doppler ultrasonography and CEUS fol-
lowed by surgery and histological examination
of the specimen. Quantitative analysis was per-
formed using perfusion software. Time intensity
curves were extracted and the following param-
eters were considered: wash-in time, time-to-
peak, maximum signal intensity and wash-out
time.
Results: Grayscale US identified 15/18 lesions;
color Doppler showed no flow signal in 8 lesions,
low color signal in 9 lesions and an intense color
signal in 1 lesion; CEUS identified 17/18 lesions
with the undetected lesion being the smallest
one (1.2 cm) located in the upper pelvicalyceal
system. Semi-quantitative analysis produced dif-
ferent data for high-grade and low-grade urothe-
lial cell carcinoma (UCC). All detected upper ur-
inary tract masses were UCCs. MRU, MDCTU
and grayscale US overestimated the tumor size,
while CEUSwas the most accurate.
Conclusion: CEUS is useful for evaluating upper
urinary tract masses as this method permits dif-
ferentiation between high-grade and low-grade
tumors as well as distinction of the tumor from
the adjacent structures and accurate mass meas-
urements.
Introduction
!
Upper urinary tract malignancies are relatively rare and account
for only 5% of urothelial cell carcinomas (UCCs) [1, 2]. Most upper
urinary tract UCCs (75%) are located in the renal pelvis and caly-
ces, while the remaining 25% are located in the ureter: 70% in the
distal ureter, 25% in themid-ureter and 5% in the proximal ureter
[3].
Multidetector computed tomographic urography (MDCTU) and
magnetic resonance urography (MRU) are widely considered to
be the best available modalities for the diagnosis and staging of
urothelial carcinoma [4–10]. The sensitivity (MDCTU 92.9–
100%; MRU 62.9–94.1 %) and specificity (MDCTU 93–100%;
MRU 81–100%) of these methods are high but diagnosis is often
based on the presence of indirect signs, such as wall thickening
and hydroureteronephrosis, rather than on the actual recogni-
tion of the lesion.
Ultrasound (US) is the first-line imaging modality in patients
with hematuria [2], as color Doppler US is useful in urological
imaging and power Doppler US improves the sensitivity in the
detection of slow blood flow [11].
The introduction of contrast-enhanced US (CEUS) has made it
possible to detect and image blood flow in small vessels usingmi-
crobubbles to assess regional microvascular perfusion in tissues
such as the liver, kidney and myocardium [12]. The advantage of
this method compared to MDCTU and MRU lies in the ability to
provide real-time images of blood flow within the lesions.
The main objective of this study was to assess the effectiveness of
CEUS in the diagnosis of upper urinary tract neoplasms compar-
ed to MDCTU and MRU which are considered to be the gold
standard. Secondary objectives were to assess the usefulness of
CEUS in distinguishing high-grade tumors from low-grade ones
on the basis of time-intensity curves and also to compare the tu-
mor size measured with CEUS, MDCTU and MRU.
Materials and methods
!
Patient population
From January 2009 to September 2011, 18 patients, 10 males and
8 females (mean age: 74; range: 62–85), were referred to diag-
nostic investigation with suspicion of upper urinary tract carci-
noma due to persistent gross hematuria (n =11) or microscopic
hematuria (n =7), positive or atypical urine cytology results but
no abnormalities at cystoscopy (●" Tab. 1).
Written informed consent was obtained from all patients, and
the procedures were in accordance with the ethical standards of
the Committee on Human Experimentation of this institution.
Imaging techniques
Investigational protocol
All patients underwent MDCTU or MRU to assess the presence of
a neoplastic lesion. They subsequently underwent grayscale US,
color Doppler (CDUS) and CEUS during the same session. The
same radiologists performed US, color Doppler and CEUS; they
were aware of the MDCTU and MRU findings.
All patients underwent surgery (nephroureterectomy with blad-
der cuff excision). The dimensions of the surgical specimen were
recorded before it was submitted to histological examination
which confirmed UCC in all cases.
MDCTU
Thirteen patients underwent MDCTU, which was performed on
64-MDCT scanners (Siemens, Erlangen, Germany) using a three-
phase protocol. 400–500ml of water were administered orally
to the patients 20 minutes before the examination. Unenhanced
CT scans of the abdomen and pelvis were obtained. Nephro-
graphic phase images were then obtained 80 sec after bolus in-
jection (2ml/kg body weight) of iohexol (Omnipaque 300, GE
Healthcare, USA) or iomeprolo (Iomeron 350, Bracco, Italy). Ex-
cretory phase images of the abdomen and pelvis were obtained
8 minutes after injection of the contrast agents. Unenhanced
and nephrographic phase scans were reconstructed with sec-
tions with a thickness of 2–5mm. The excretory phase scan was
reconstructed as sections with a thickness of 1.25mm.
MRU
Five patients underwent MRU, which was performed on 1.5 T
(Siemens) scanners. Multisequence MRI was carried out includ-
ing T1-weighted and T2-weighted sequences (slice thickness:
6.6–7.7mm). Diffusion-weighted imaging (DWI) was carried
out with single-shot spin-echo planar imaging sequences (slice
thickness: 6–7mm). Spectral attenuated inversion recovery
(SPAIR) fat suppression was performed under free-breathing ac-
quisition. In the dynamic contrast-enhanced (DCE) MRI sequen-
ces, 24 slices were sequentially acquired 30, 80, and 180 sec after
administration of meglumine gadopentetate (0.1ml/kg body
weight).
US and CDUS
All patients underwent grayscale US and CDUS.US examination
was performed on Aplio (Toshiba, Tokyo, Japan), MyLab and
MyLab-Twice (Esaote, Genoa, Italy) using a 3.5–5MHz multi-
frequency broadband convex transducer. Examination was per-
formedwhen the urinary bladder was adequately full to visualize
the possible presence of lesions in the ureteral-bladder junction.
The location and size of the lesions detected during grayscale US
were recorded. CDUS was performed using scanning parameters
set for maximum sensitivity for slow flow while the power out-
put was increased to maximum. Color gain was increased to the
point just before the appearance of random noise. The pulse re-
petition frequency was set at the lowest possible level. The ima-
ges were assigned the following scores: 0 =no color signal, 1 = low
color signal, 2 = intense color signal.
CEUS
In the same session all patients underwent real-time continuous
examination using a low mechanical index (range: 0.04–0.1)
after the administration of SonoVue (Bracco™). SonoVue is a
blood pool US contrast agent comprising microbubbles. A total
of 4.8ml was administered in 2 intravenous bolus doses of 2.4
ml; the second dose was injected 15 minutes after the first and
von hoch- und niedriggradigen Tumoren sowie die Abgrenzung
des Tumors von den umgebenden Strukturen und eine exakte
Größenbestimmung der Raumforderung ermöglicht.
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both were followed by 5ml of a saline flush. The second injection
was performed to evaluate the contralateral urinary tract.
Still images of the entire examination were digitally recorded on
magnetic optical disk. Recording was initiated at the start of the
first contrast injection and at the start of the second injection. All
time measurements started at these points, which were “time-0”
in all recorded video clips.
The images were analyzed off-site at consensus conferences to
determine the size of the lesion, baseline and CDUS appearance
as well as the signal intensity of the enhancement after SonoVue
administration.
The images were interpreted by the two radiologists who per-
formed the examination. Both were skilled in urologic US and
had more than 5 years of CEUS examination experience.
Perfusion software was then used to estimate the perfusion pat-
tern (Qontrast v 3.0, Bracco, Milan, Italy) [13]. This quantitative
software analyzes the temporal sequence of the images. Time-in-
tensity curves (TIC) were extracted from regions of interest in the
lesion, and TIC quantitative analysis was performed. The follow-
ing parameters were considered: wash-in time, time-to-peak
(TTP), maximum signal intensity (SI) and wash-out time. The sig-
nal intensity was calculated for every pixel for every second, thus
generating maps of perfusion parameters.
Statistical analysis
The paired T-test was performed to evaluate the statistical signif-
icance of the measurements obtained using the four imaging
techniques. The measurements were compared to the actual
length of the lesion measured on the surgical specimen.
Results
!
MRU and MDCTU identified upper urinary tract masses in all
18 patients, who subsequently underwent CEUS.Histological
examination after surgery confirmed UCC in all patients. The
lesions were located as follows: 9 (50%) in the distal ureter;
4 (22.2 %) in the mid-ureter; 3 (16.6 %) in the proximal ureter;
2 (11.2%) in the pelvicalyceal system. The mean dimension was
3.1 cm (range 1.2–7.1 cm).
In MDCTU and MRU, 18 lesions exhibited enhancement. In the
urographic phase, the lesions did not exhibit direct enhance-
Tab. 1 Patient population.1age sex location symptoms specimen length
(cm)
urine cytology grading
1 81 M DU Gross
Hematuria
2.3 P UCC-HG
2 72 M DU Gross
Hematuria
2.7 P UCC-HG
3 69 M PU Gross
Hematuria,
Flank Pain
3.2 P UCC-LG
4 63 F C Microscopic
Hematuria
1.2 P UCC-HG
5 75 F DU Microscopic
Hematuria
2.4 A UCC-LG
6 74 M MU Gross
Hematuria
1.9 P UCC-LG
7 81 M DU Microscopic
Hematuria
2.5 P UCC-HG
8 79 F DU Gross
Hematuria
3.1 P UCC-LG
9 84 F PU Gross
Hematuria
3.8 P UCC-LG
10 70 M MU Microscopic
Hematuria
2.1 A UCC-LG
11 68 F DU Microscopic
Hematuria
2.5 P UCC-HG
12 72 M PU Gross
Hematuria
4.1 A UCC-LG
13 70 M DU Gross
Hematuria
Flank Pain
3.9 P UCC-LG
14 73 F MU Gross
Hematuria
2.5 A UCC-LG
15 85 M MU Microscopic
Hematuria
7.1 P UCC-HG
16 62 M DU Microscopic
Hematuria
3.5 P UCC-LG
17 79 F DU Gross
Hematuria
4.3 P UCC-HG
18 73 F C Gross
Hematuria
3.3 A UCC-LG
1 M: male, F: female, DU: distal ureter, MU: mid ureter, PU: proximal ureter, C: pielo-calyceal system, P: positive, A: atypical, UCC: urothelial
cell carcinoma, HG: high grade, LG: low grade.
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ment, and the diagnosis of upper urinary tract neoplasm was
made on the basis of indirect indicators. The lesion sizemeasured
on MDCTU and MRU images was found to be 15–20% greater
than the actual size of the surgical specimen.
Grayscale US identified 15 out of 18 lesions (83.3 %). One lesion in
the upper pelvicalyceal system and 2 in the mid-ureter were not
identified. The lesion size measured on grayscale US images was
found to be about 25% greater than the actual size of the surgical
specimen.
In CDUS the 15 lesions presented different color signals: 7 lesions
exhibited no flow signal (score 0); 7 presented low color signal
(score 1); 1 exhibited intense color signal (score 2).
In CEUS 17 patients were found positive for upper urinary tract
neoplasm, while 1 was found negative. The undetected lesion
was small (1.2 cm) and located in the upper pelvicalyceal system
of the kidney. It was not identifiedwith grayscale US. CEUS exam-
ination therefore resulted in 17 true-positive cases and 1 false-
negative case, yielding a sensitivity of 94.4%.
The lesion size measured on the CEUS images came close to the
actual dimensions of the surgical specimen (●" Tab. 2). In CEUS
all detected lesions exhibited homogeneous enhancement in ev-
ery part of the lesion.
The paired T-test results were: US vs. specimen P>0.50; MDCTU/
MRU vs. specimen P>0.50; CEUS vs. specimen P<0.05.
TIC and semi-quantitative analysis produced the following re-
sults: high-grade UCCs: wash-in after 13–18 sec, TTP >30 sec, SI
> 55%, wash-out time >80 secs; low-grade UCCs: wash-in time
10 sec, TTP <25 sec, SI < 50%, wash-out time <50 sec (●" Tab. 3)
[2].
Tab. 2 Urothelial lesions; length (cm).
US MDCTU\MRU CEUS specimen
2.8 2.7 2.4 2.3
3.3 3.2 2.8 2.7
4.0 3.7 3.4 3.2
unidentified 1.4 unidentified 1.2
3.0 2.8 2.5 2.4
2.4 2.3 2.0 1.9
3.1 2.8 2.6 2.5
3.9 3.5 3.2 3.1
4.8 4.4 4.0 3.8
unidentified 2.4 2.2 2.1
3.1 3.0 2.6 2.5
5.0 4.8 4.3 4.1
4.8 4.6 4.1 3.9
unidentified 2.9 2.6 2.5
8.1 7.9 7.3 7.1
4.4 4.0 3.7 3.5
5.2 5.0 4.5 4.3
4.3 3.8 3.5 3.3
Tab. 3 HG-UCC e LG-UCC in bladder and upper urinary tract (UUT).
HG-UCC LG-UCC
Bladder UUT Bladder UUT
wash-in
time
13 sec 13 – 18 sec 10 sec 10 sec
TTP > 28 sec > 30 sec < 26 sec < 25 sec
SI > 50 % > 55 % < 50 % < 50 %
wash-
out time
58 sec > 80 sec < 50 sec < 50 sec
Fig. 1 A 63-year-old woman with high-grade UCC
located in the upper pelvicalyceal group of the left
kidney: aMDCTU shows a small mass in the calyceal
cavity of the upper pole (red arrow); b MRU con-
firms the presence of the lesion (yellow arrow);
c CDUS does not show the lesion, normal vascular-
ity of the renal parenchyma; d US (left: gray-scale;
right: CEUS): the lesion is not identified; e Surgical
specimen: lesion length 12mm (black arrow).
Abb.1 Eine 63-jährige Frau mit hochgradigem
UCC, welches im oberen Nierenbeckenkelch-
systems der linken Niere lokalisiert ist: a MDCTU
zeigt eine kleine Raumforderung im Kelchraum des
oberen Pols (roter Pfeil); b MRU bestätigt den
Herdbefund (gelber Pfeil); c CDUS zeigt keine
Läsion, normale Vaskularität des Nierenparench-
yms; d US (links: B-Bild, rechts: CEUS): die Läsion
wird nicht erkannt; e Operationspräparat: Länge
des Herdes 12mm (schwarzer Pfeil).
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Discussion
!
MDCTU and MRU are the gold standard for imaging of the upper
urinary tract and have replaced intravenous excretory urography
[14–16]. Analysis of the data available in the literature shows
that the sensitivity and specificity of MDCTU are close to 100%
with a greater sensitivity and specificity in lesions located in the
renal pelvis (100%) than in the ureter (92.9 %) [1, 16–18].
Fig. 2 An 81-year-old man with high-grade UCC
located in the left distal ureter: a MDCTU shows
moderate hydroureteronephrosis of the urinary
tract, the lesion is moderately enhanced (red ar-
row); b CDUS: the lesion is poorly vascularized
(score 1) and the margins are blurred due to the
presence of intraluminal artifacts (yellow arrow)
(length 38mm); c CEUS: average late-phase
enhancement of the lesion (length 25mm) (green
arrows); d TIC showing the following values: wash-
in time 13 sec, TTP 29 sec, SI > 60 and wash-out
time >80 sec suggesting high-grade UCC.
Abb.2 Ein 81-jähriger Mann mit hochgradigem
UCC in der linken distalen Harnröhre: a MDCTU
zeigt eine moderate Hydroureteronephrose des
Harntraktes; die Läsion ist mäßig verstärkt (roter
Pfeil); b CDUS: die Läsion ist schlecht vaskularisiert
(Grad 1) und die Ränder sind aufgrund intralumina-
ler Artefakte verschwommen (gelber Pfeil) (Länge
38mm); c CEUS: durchschnittliche Signalverstär-
kung der Läsion in der Spätphase (Länge 25mm)
(grüne Pfeile); d TIC zeigt folgende Werte: Wash-in-
Zeit 13 s, TTP 29 s, SI > 60 und Wash-out-Zeit > 80 s,
was für ein hochgradiges UCC spricht.
Fig. 3 A 79-year-old woman with high-grade UCC located in the left distal
ureter: aMDCTU shows left-sided hydroureteronephrosis and thickening of
the distal ureter with poor enhancement (red arrow); b US (left: CEUS; right:
gray-scale) intense enhancement of the lesion (green arrows) (length
43mm), in the right image, intraluminal artifacts (yellow arrow) do not
permit an accurate measurement; c Surgical specimen, lesion length
measured on the specimen corresponds to measurement made at CEUS;
d TIC showing the following values: wash-in time 14 seconds, TTP 35 sec,
SI > 64 and wash-out time >80 sec suggesting high-grade UCC.
Abb.3 Eine 79-jährige Frau mit hochgradigem UCC in der linken distalen
Harnröhre: aMDCTU zeigt eine linksseitige Hydrourethernephrose und eine
Verdickung des distalen Urethers mit geringer Signalverstärkung (roter
Pfeil); b im US (links: CEUS, rechts: B-Bild) hochgradige Signalverstärkung
der Läsion (grüne Pfeile) (Länge 43mm), in der rechten Abbildung, die in-
traluminalen Artefakte (gelber Pfeil) lassen keine genaue Messung zu;
c Operationspräparat: die am Präparat gemessene Größe der Läsion
entspricht der Messung mittels CEUS; d TIC zeigt folgende Werte: Wash-in-
Zeit 14 s, TTP 35 s, SI > 64 und Wash-out-Zeit > 80 s, was für ein hochgradi-
ges UCC spricht.
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In the literature, the two most common sequences in MRU are
T2-weighted hydrographic sequences without contrast agent
and T1-spoiled gradient-recalled echo (GRE) sequences during
the excretory phase after gadolinium administration [19, 20]
with a sensitivity of 62.9–76.5 % and a specificity of 89–100%
[20, 21]. The use of DWI sequences substantially increases the
sensitivity to up to 94.1%, as compared to T1 and T2 sequences
[9, 10].
In the present study, 18/18 lesions exhibited enhancement in
MDCTU and MRU. During the urographic phase the lesions were
diagnosed on the basis of other indicators such as thickening of
the ureter wall or pelvicalyceal system as well as filling defects
which were particularly evident in the 7 cases (38.8%) affected
by hydroureteronephrosis [17, 20, 22].
In grayscale US, UCC of the renal pelvis typically appears as a solid
mass which is difficult to distinguish from the renal sinus, parti-
cularly in the absence of hydronephrosis [23–25]. US has a lim-
ited role in the evaluation of UCC of the ureter as the ureter is
rarely visualized in its entirety, even if dilated. When visualized,
these tumors are typically intraluminal soft-tissue masses with
proximal distention of the ureter.
In the present study, grayscale US identified 15 lesions, while 3
were not identified. Two of the unidentified lesions were located
in the mid-ureter and there was mild dilation of the ureter. The
third undetected lesionwas the smallest (1.2 cm) andwas located
in the upper pelvicalyceal system.
The use of color Doppler did not significantly increase US sensi-
tivity owing to the frequent absence of a vascular signal within
the neoplastic lesion: 7 lesions out of 18 (38.8 %) were assigned
a score of 0.
In CEUS, 17 lesions out of 18 (94.4%) exhibited enhancement of-
fering direct visualization of the lesion. The lesion that was not
detected in CEUS was located in the upper pelvicalyceal system
of the kidney and was not identified in grayscale US (●" Fig. 1). It
probably went undetected because of the intense enhancement
of the renal parenchyma which masked the enhancement of the
Fig. 4 An 85-year-old man with high-grade UCC located in the right mid
ureter: a Retrograde pyelography shows filling defect of the ureter (red ar-
row); b Gray-scale US shows a solid mass in the lumen of the right ureter
(yellow arrows), the iliac artery and vein are visible below; c CDUS shows
poor vascular signal within the lesion (score 1); d CEUS shows homoge-
neous enhancement of the neoplastic lesion (green arrows) (length
70mm); e Surgical specimen: lesion length is 71mm; f TIC showing the
following values: wash-in time 13 sec, TTP 31 sec, SI 44 and washout time
>80 sec suggesting high-grade UCC.
Abb.4 Ein 85-jähriger Mann mit hochgradigem UCC in der rechten mit-
tleren Harnröhre: a Die retrograde Pyelografie zeigt die Füllung des Harn-
leiters (roter Pfeil); b das B-Bild zeigt eine kompakte Raumforderung im
Lumen des rechten Urethers (gelbe Pfeile), die Arterie und Vene des Beck-
ens sind darunter sichtbar; c CDUS zeigt ein schlechtes vaskuläres Signal
innerhalb der Läsion (Grad 1); d CEUS zeigt eine homogene Signalverstär-
kung der neoplastischen Läsion (grüne Pfeile) (Länge 70mm);
e Operationspräparat: Die Länge der Läsion beträgt 71mm; f TIC zeigt die
folgenden Werte: Wash-in-Zeit 13 s, TTP 31 s, SI 44 und Wash-out-Zeit
> 80 s spricht für ein hochgradiges UCC.
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lesion. TTP of the renal parenchyma occurred about 18 sec after
the first injection of contrast agent and wash-out took more
than 5 min thereby completely masking the lesion. In the present
patient population, CEUS identified another lesion located in the
calyceal cavity as it was larger and caused swelling of the renal
pelvis. This may indicate a greater sensitivity of CEUS in masses
located in the ureter (16 out of 16 lesions were identified; sensi-
tivity 100%) than in smaller lesions located in the calyceal system
(1 out of 2 lesions was identified; sensitivity 50%). The overall
sensitivity of CEUS was 94.4 %. Because of the lack of false-posi-
tive and true-negative patients, the sensitivity was the only sta-
tistical datum that could be extrapolated about CEUS in the de-
tection of upper urinary tract UCCs.
MDCTU and MRU overestimated tumor size by 15–20%. This
phenomenon is probably due to the fact that it is difficult to dif-
ferentiate between the lesion and the ureteral walls or the caly-
ceal walls because of concurrent enhancement of the lesion and
the surrounding wall with no neoplasm [26].
Grayscale US also overestimated tumor size by about 25%. In
most cases this phenomenon is linked to the presence of intra-
luminal echoes due to artifacts, cellular debris and/or blood clots.
CEUS yielded tumor sizes close to the actual dimensions of the
surgical specimens as amplitude subtraction permitted the sup-
pression of intraluminal echoes caused by artifacts (●" Fig. 2, 3).
Agreement between the actual tumor size of the surgical speci-
men and the size measured in CEUS shows that areas exhibiting
enhancement in CEUS are actually neoplastic lesions.
The fact that CEUS showed a vascular signal from the lesion in an
elevated percentage of cases, i. e., higher than CDUS and close to
MDCTU/MRU (CEUS 94%; CDUS 61%; MDCTU/MRU 100% of
cases), may be attributed to the ability of the US blood pool con-
trast agent to provide real-time depiction of the lesion vascular-
ity.
The clips obtained in CEUSwere used for the construction of TICs
for the comparison between enhancement patterns of high-
grade and low-grade UCCs. This semi-quantitative analysis was
compared to data obtained from studies of the bladder [27, 28].
Semi-quantitative analysis of high-grade and low-grade UCCs of
the urinary tract yielded results similar to those related to blad-
der cancer.
The only contrasting data with regard to the signal intensity of
high-grade UCCs was a case in which the lesion was located in
the mid-ureter in close proximity to the iliac artery. In this case
the SI was lower than the SI observed in the other cases. The close
proximity of the iliac artery, where there were high concentra-
tions of contrast agent, may have altered the SI measurement of
the neoplastic lesion (●" Fig. 4).
The limitations of this study are related to the patient population.
The first limitation is the low number of patients which is partly
due to the relative rarity of upper urinary tract UCCs. Only 5–
10% of UCCs affect the upper urinary tract, while the remaining
90–95% are located in the bladder [2]. The second limitation is
related to the selection criteria, as all the recruited patients al-
ready had a MDCTU and/or MRU report positive for the presence
of an upper urinary tract lesion and urinary cytology positive for
malignant cells. However, this was needed to assess the reliability
of CEUS in the detection of upper urinary tract UCCs.
Conclusions
!
The results of this study show that CEUS is a useful tool for evalu-
ating upper urinary tract tumors as nearly all lesions were de-
tected. CEUS allows a semi-quantitative analysis for differentiat-
ing the degree of malignancy, an accurate measurement of the
mass by image subtraction, thus avoiding artifacts, and distinc-
tion of the tumor from adjacent structures based on enhance-
ment timing.
CEUSmay become a first-line examination in the diagnosis of up-
per urinary tract masses because of the short execution time and
relatively low cost and thereby become an alternative toMRU and
MDCTU in patients who are allergic to contrast agents or are af-
fected by renal failure. However, further studies involving larger
patient populations are mandatory to confirm these encouraging
preliminary results.
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